Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.

@article{Kuusela1984ComparisonOC,
  title={Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.},
  author={Pentti Kuusela and Hannu J Jalanko and Peter J. Roberts and Pentti Ilmari Sipponen and J. P. Mecklin and Reino I Pitk{\"a}nen and Olli T M{\"a}kel{\"a}},
  journal={British Journal of Cancer},
  year={1984},
  volume={49},
  pages={135 - 139}
}
The serum levels of CA 19-9 and carcinoembryonic antigen (CEA) were determined in 37 patients with benign colorectal diseases and in 111 patients with newly discovered colorectal carcinomas or clinically verified relapses. In cancer patients, the CA 19-9 level ranged from normal (0-37 U ml-1) to 77,500 U ml-1 whereas all samples but one from patients with benign colorectal diseases had a normal value. CA 19-9 was increased in 46% and 45% of patients with an advanced (Dukes C or D) carcinoma or… CONTINUE READING